Calamos Advisors’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-34,047
Closed -$1.55M – 1204
2025
Q4
$1.55M Sell
34,047
-705
-2% -$31.4K 0.01% 640
2025
Q3
$1.47M Buy
34,752
+20,062
+137% +$756K 0.01% 659
2025
Q2
$457K Sell
14,690
-39,310
-73% -$1.06M ﹤0.01% 756
2025
Q1
$1.33M Sell
54,000
-9,029
-14% -$251K 0.01% 626
2024
Q4
$1.8M Buy
63,029
+33,541
+114% +$930K 0.01% 619
2024
Q3
$785K Buy
+29,488
New +$766K ﹤0.01% 691

Other funds holding AORT

Calamos Advisors's AORT Position: Q1 2026 in Review

Calamos Advisors sold out of Artivion (AORT) in Q1 2026, closing a stake of 34,047 shares — an estimated $1.55M sold.

Calamos Advisors first reported a position in AORT in Q3 2024 and held it in 6 quarters. The position peaked at $1.8M in Q4 2024. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Calamos Advisors reported no remaining Artivion position as of Q1 2026 after selling out during the quarter.
  • Calamos Advisors sold 34,047 Artivion shares in Q1 2026, an estimated $1.55M.
  • Calamos Advisors first reported a position in Artivion in Q3 2024 and held it in 6 quarters.
  • Calamos Advisors's Artivion position peaked at $1.8M in Q4 2024.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.